Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

925.265
-8.623-0.92%
Number of Gainers:2
Number of Losers:15
Number of Flat:- -
PE:- -
High:930.611
Open:930.611
Low:904.457
Close:933.888
Volume:536.53M
Turnover:4.82B
Market Cap:620.70B
Float Cap:517.91B

Loading ...

Tong Ren Tang Technologies Receives Official Registration for New Chinese Medicine Granules

Stock News
·
Aug 28

Tong Ren Tang Technologies Inks E-Commerce Framework Agreement with Tong Ren Tang Digital Technology

Stock News
·
Aug 28

Beijing Tongrentang Technologies Reports H1 Net Profit of RMB249 Million, Down 26.4% Year-on-Year

Stock News
·
Aug 28

Chinese Traditional Medicine Maker Tong Ren Tang Profit Falls on Weaker Demand

Reuters
·
Aug 28

Tong Ren Tang Chinese Medicine Wins Hong Kong Registration for Sanzi Yangqin Keli Product

Reuters
·
Aug 28

Tong Ren Tang Technologies Signs New E-Commerce Services Deal with Tong Ren Tang Shuzi Technology Through 2028

Reuters
·
Aug 28

Tong Ren Tang Technologies H1 Net Income Attributable RMB 249.1 Million

THOMSON REUTERS
·
Aug 28

Tong Ren Tang Technologies - Board Does not Declare the Distribution of an Interim Dividend

THOMSON REUTERS
·
Aug 28

Tong Ren Tang Tech FY26 H1 Profit Attributable to Owners Drops 26.43% to RMB 249.14 Million; Revenue Falls 19.1% to RMB 3.02 Billion

Reuters
·
Aug 28

Fosun Pharma Allocates 725,100 A-Share Options to Employees

Stock News
·
Aug 28

BYD Electronic Reports Interim Results: Shareholder Profit Plunges 75% to RMB 426 Million

Stock News
·
Aug 28

BYD Electronic (International)'s Attributable Profit Slides 75% in H1

MT Newswires Live
·
Aug 28

China's BYD Electronic H1 Profit Drops 75% as Smart Terminal Business Weakens

Reuters
·
Aug 28

Sinopharm's Subsidiary Reports 6.06 Billion Yuan Net Profit for First Half, Down 8.97% Year-on-Year

Stock News
·
Aug 28

BYD Electronic FY26 H1 Profit Attributable to Owners Drops 75.35% to RMB 426 Million; Revenue Rises 2.02% to RMB 82.23 Billion

Reuters
·
Aug 28

BYD Electronic International H1 Net Income Attributable RMB 426 Million

THOMSON REUTERS
·
Aug 28

Sinopharm Accord, Sinopharm Group Unit, Posts H1 Net Profit Attributable to Shareholders Down 8.97% to RMB 606.2 Million

Reuters
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Disposal of First New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for Rmb146.3 Mln

THOMSON REUTERS
·
Aug 28

Sino Biopharm Wins NMPA Nod to Start LM-364 Nectin-4 TME ADC Trial in Solid Tumors

Reuters
·
Aug 28

Sino Biopharmaceutical - Lm-364 'Nectin-4Tme ADC' Receives Nmpa Clinical Trial Approval for Advanced Solid Tumors

THOMSON REUTERS
·
Aug 28